Skip to main content

Table 1 The yearly RCC patients’ incidence and death estimation in USA

From: Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

Year Total RCC cases Total death Death rate (%) References
2021 76,080 13,780 18.1 [4]
2020 73,750 14,830 20.1 [5]
2019 73,820 14,770 20.0 [6]
2018 65,340 14,970 22.9 [7]
2017 63,990 14,400 22.5 [8]
2016 62,700 14,240 22.7 [9]
2015 61,560 14,080 22.9 [10]
2014 63,920 13,860 21.7 [11]
2013 65,150 13,680 21.0 [12]
2012 64,770 13,570 20.8 [13]
2011 60,920 13,120 21.5 [14]
2010 58,240 13,040 22.4 [15]